Kazia Therapeutics LTD balance sheet

At the end of fiscal 2025, Kazia Therapeutics LTD had total assets of $4.0m, total liabilities of $9.4m and shareholders' equity of −$5.5m. It held $2.9m in cash against $260,291 of debt: net cash of $2.6m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Kazia Therapeutics LTD: balance sheet, annual
Fiscal year	2016Jun 2016	2017Jun 2017	2018Jun 2018	2021Jun 2021	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025
Cash and equivalents	25	11	4	21	5	3	1	3
Receivables	—	3	2	0	0	3	3	0
Total current assets	—	15	7	22	7	7	4	3
Total assets	—	28	21	43	25	19	14	4
Total current liabilities	—	4	3	4	5	5	17	9
Short-term debt	—	—	—	0	1	1	0	0
Total debt	0	0	0	0	1	1	0	0
Total liabilities	—	8	7	14	12	11	21	9
Shareholders' equity	25	19	14	28	13	8	−7	−5
Net debt (negative = net cash)	−25	−11	−4	−21	−4	−2	−1	−3

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: KZIA vs LYEL AIM vs KZIA IBIO vs KZIA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Kazia Therapeutics LTD's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Kazia Therapeutics LTD.